Kave Moloudi

517 total citations
21 papers, 384 citations indexed

About

Kave Moloudi is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Kave Moloudi has authored 21 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomedical Engineering, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Biomaterials. Recurrent topics in Kave Moloudi's work include Nanoplatforms for cancer theranostics (9 papers), Photodynamic Therapy Research Studies (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Kave Moloudi is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Photodynamic Therapy Research Studies (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Kave Moloudi collaborates with scholars based in South Africa, Iran and France. Kave Moloudi's co-authors include Heidi Abrahamse, Blassan P. George, Masoud Najafi, Shahram Taeb, Bagher Farhood, Ali Khani, Jaber Beik, Ali Shakeri‐Zadeh, Habib Ghaznavi and Reza Paydar and has published in prestigious journals such as RSC Advances, Current Pharmaceutical Design and Frontiers in Oncology.

In The Last Decade

Kave Moloudi

19 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kave Moloudi South Africa 12 169 118 101 72 58 21 384
Fushan Tang China 13 103 0.6× 199 1.7× 177 1.8× 50 0.7× 26 0.4× 40 515
Ishwor Poudel United States 10 129 0.8× 135 1.1× 179 1.8× 18 0.3× 20 0.3× 24 432
Pallavi Chand India 8 127 0.8× 149 1.3× 139 1.4× 24 0.3× 39 0.7× 10 364
Nusrat Chowdhury United States 15 131 0.8× 152 1.3× 233 2.3× 42 0.6× 31 0.5× 20 543
Lingran Du China 11 141 0.8× 109 0.9× 188 1.9× 41 0.6× 59 1.0× 22 457
Muhammad Kashif Riaz Hong Kong 9 236 1.4× 382 3.2× 393 3.9× 94 1.3× 45 0.8× 11 798
Giorgia Ailuno Italy 11 62 0.4× 66 0.6× 140 1.4× 32 0.4× 54 0.9× 25 412
Xiaoyang Chu China 13 221 1.3× 246 2.1× 295 2.9× 22 0.3× 50 0.9× 25 614
Faraz Zarghami Iran 6 65 0.4× 90 0.8× 184 1.8× 36 0.5× 43 0.7× 7 349

Countries citing papers authored by Kave Moloudi

Since Specialization
Citations

This map shows the geographic impact of Kave Moloudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kave Moloudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kave Moloudi more than expected).

Fields of papers citing papers by Kave Moloudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kave Moloudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kave Moloudi. The network helps show where Kave Moloudi may publish in the future.

Co-authorship network of co-authors of Kave Moloudi

This figure shows the co-authorship network connecting the top 25 collaborators of Kave Moloudi. A scholar is included among the top collaborators of Kave Moloudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kave Moloudi. Kave Moloudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moloudi, Kave, et al.. (2025). An update on recent advances in fluorescent materials for fluorescence molecular imaging: a review. RSC Advances. 15(28). 22267–22284. 3 indexed citations
2.
Moloudi, Kave, Heidi Abrahamse, & Blassan P. George. (2025). Liposomes-based co-delivery of pheophorbide a and gold nanoparticles for thermo-photodynamic therapy purpose on lung cancer spheroids. Results in Chemistry. 15. 102234–102234. 1 indexed citations
3.
Moloudi, Kave, Heidi Abrahamse, & Blassan P. George. (2025). Photodynamic therapy-induced inflammation and adverse effects: An updated review. Biomedical Journal. 100889–100889. 1 indexed citations
5.
Moloudi, Kave, Heidi Abrahamse, & Blassan P. George. (2024). Application of liposomal nanoparticles of berberine in photodynamic therapy of A549 lung cancer spheroids. Biochemistry and Biophysics Reports. 40. 101877–101877. 3 indexed citations
6.
Moloudi, Kave, Heidi Abrahamse, & Blassan P. George. (2024). Co-delivery of berberine and gold nanoparticles on liposomes for photodynamic therapy against 3D lung cancer cells. Materials Advances. 5(15). 6185–6195. 9 indexed citations
7.
Moloudi, Kave, et al.. (2024). Expected role of photodynamic therapy to relieve skin damage in nuclear or radiological emergency: Review. Environmental Toxicology and Pharmacology. 110. 104517–104517. 1 indexed citations
8.
Moloudi, Kave, Heidi Abrahamse, & Blassan P. George. (2023). Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: review. Frontiers in Oncology. 13. 1225694–1225694. 24 indexed citations
9.
Moloudi, Kave, Paromita Sarbadhikary, Heidi Abrahamse, & Blassan P. George. (2023). Understanding the Photodynamic Therapy Induced Bystander and Abscopal Effects: A Review. Antioxidants. 12(7). 1434–1434. 18 indexed citations
10.
Moloudi, Kave, et al.. (2023). Immunoregulation by resveratrol; implications for normal tissue protection and tumour suppression. Clinical and Experimental Pharmacology and Physiology. 50(5). 353–368. 28 indexed citations
11.
Moloudi, Kave, Ali Khani, Masoud Najafi, et al.. (2023). Critical parameters to translate gold nanoparticles as radiosensitizing agents into the clinic. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 15(6). e1886–e1886. 24 indexed citations
12.
Moloudi, Kave, Heidi Abrahamse, & Blassan P. George. (2023). Nanotechnology‐mediated photodynamic therapy: Focus on overcoming tumor hypoxia. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 16(1). e1937–e1937. 19 indexed citations
13.
Moloudi, Kave, et al.. (2023). Induction of Cancer Cell Death by Apigenin: A Review on Different Cell Death Pathways. Mini-Reviews in Medicinal Chemistry. 23(14). 1461–1478. 20 indexed citations
14.
Narmani, Asghar, Kave Moloudi, Seyed Mohammad Hosseini, et al.. (2023). Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy. Expert Opinion on Drug Delivery. 20(7). 937–954. 65 indexed citations
15.
Khani, Ali, Morteza Eskandani, Hossein Derakhshankhah, et al.. (2022). A novel stimuli-responsive magnetic hydrogel based on nature-inspired tragacanth gum for chemo/hyperthermia treatment of cancerous cells. Journal of Polymer Research. 29(4). 22 indexed citations
16.
Ashrafizadeh, Milad, Shahram Taeb, Hamed Haghi‐Aminjan, et al.. (2020). Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review. Anti-Cancer Agents in Medicinal Chemistry. 21(17). 2327–2336. 52 indexed citations
17.
Moloudi, Kave, Hadi Samadian, Mehdi Jaymand, et al.. (2020). Iron oxide/gold nanoparticles‐decorated reduced graphene oxide nanohybrid as the thermo‐radiotherapy agent. IET Nanobiotechnology. 14(5). 428–432. 18 indexed citations
18.
Moloudi, Kave, Reza Paydar, Ziaeddin Abed, et al.. (2018). Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy. Journal of Biomaterials Applications. 33(2). 161–169. 62 indexed citations
19.
Moloudi, Kave, et al.. (2018). Effects of artifact removal on cone-beam computed tomography images. Dental Research Journal. 15(2). 89–89. 2 indexed citations
20.
Moloudi, Kave, et al.. (2017). Synergistic Effects of Arsenic Trioxide and Radiation: Triggering of Intrinsic Pathway of Apoptosis. Iranian Biomedical Journal. 21(5). 330–337. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026